US EditionPublished • loading... • Updated
1 Pharmaceutical Stock Set to Rebound in 2026
Summary by The Motley Fool
1 Articles
1 Articles
1 Pharmaceutical Stock Set to Rebound in 2026
Key PointsNovo Nordisk stock lost 40% of its value in 2025.The stock is already trading up 22% in 2026.10 stocks we like better than Novo Nordisk › 2025 was a miserable year to own Novo Nordisk (NYSE: NVO) stock. Shares of the Danish pharmaceuticals giant and inventor of Wegovy and Ozempic crashed 40% last year as the company steadily lost market share to rivals such as Eli Lilly (NYSE: LLY), which has competing Mounjaro and Zepbound drugs, and …
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
